The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma

NCT01942993 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped standard of care has changed

Conditions

Melanoma

Interventions

DRUG: Vemurafenib

Sponsor

Philip Friedlander

Collaborators

[object Object]